• Publications
  • Archives
  • BCIQ
  • Conferences
  • Free Trial / Subscribe
  • Sign In
  • English
  • 简体中文
  • 日本語
  • 한국어
Biocentury

// BCIQ

Menu Menu
  • Home Today
  • Publications Publications
    • Publications Home
    • BioCentury
    • BC Innovations
    • BC Extra
    • BC Week In Review
    • Current Issues
  • Archives Archives
    • Archives Home
    • Basic Search
    • Advanced Search
    • Back Issues
  • BCIQ BCIQ
    • BCIQ Home
    • Overview
    • Newsfeed
    • Companies
    • Products
    • Finance
    • Deals
  • Conferences Conferences
    • Conferences Home
    • Newsmakers
    • Bio€quity Europe
    • Future Leaders
    • China Healthcare Summit
    • Other Industry Events
  • eLearning Interact
    • eLearning Home
    • Videos
    • White Papers
    • Follow Us

      Twitter LinkedIn RSS

X
  • Newsfeed
  • Companies
  • Products
  • Finance
  • Deals
  • Profile Reports
  • Overview
  • Pipeline
  • Deals
  • Financings
  • Earnings Summary
  • Stock Summary
  • Articles

1 documents

  • BC Innovations 1
    • Distillery Therapeutics 1
Read All
07:00 , Jun 16, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Deoxyribonuclease I like 3 (DNASE1L3)

Autoimmune disease INDICATION: Lupus Patient sample and mouse studies suggest DNASE1L3 could help treat lupus caused by mutations in the gene. In vitro, sera from DNASE1L3-deficient mice and lupus patients digested less DNA from apoptotic...
Read More
About Biocentury
  • Company Overview
  • Management
  • Editorial & Research
  • Market data
Contact
  • Contact Us
  • Advertising & Sponsorship
  • Career Opportunities
Support
  • Customer Service
  • Reprints
  • FAQs
Products & Solutions
  • Products Overview
  • Publications
  • Archives
  • BCIQ
  • Conferences
  • eLearning
  • RSS Feeds
Legal
  • User Agreement
  • Terms of Use
  • Privacy Policy
  • Your California Privacy Rights
  • Use of Images
  • Market data
  • Follow Us

    Twitter LinkedIn RSS

© 2018 BioCentury Inc. All Rights Reserved.    Terms & Conditions | Privacy Policy